The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.

The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.

The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against surrogate advertising of ...

In an Untitled Letter, regulators said Facebook promotions for Pfizer’s lymphoma therapy overstated its approved use and ...

Medicine commercials always lying (SNAX) — they make everything look so quick, easy, and magically perfect. But in reality, ...

A Stanford and Mount Sinai project won a top prize at a global competition for agentic AI in Alzheimer's research.

Eating disorder therapist Carolyn Karoll said the pursuit of weight loss can fuel negative body image and even trigger eating ...

Collaboration with leading European orthopedic center in Italy supports GelrinC® clinical adoptionRenowned cartilage ...

The FDA is seeking (PDF) new powers to hold companies accountable for misleading direct-to-consumer (DTC) ads, adding legislat | The FDA is seeking new powers to hold companies accountable for ...

Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors, ...

The state legislature approved the funding for UTHSC's construction of the College of Medicine Interdisciplinary Building.

A Hartlepool man involved in drug dealing in the town has been jailed for almost five years. David Abbott was arrested along ...